Molecular Partners AG (XSWX:MOLN)
CHF 3.305 -0.115 (-3.36%) Market Cap: 108.63 Mil Enterprise Value: -74.61 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 53/100

Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 10, 2021 / 03:00PM GMT
Release Date Price: CHF18.4 (-1.08%)
James Patrick Quigley;Patrick
Morgan Stanley, Research Division - Equity Analyst

Right. So good morning and good afternoon, everyone. I am James Quigley, European pharma and biotech analyst at Morgan Stanley. It's my pleasure to welcome you all to this session with Molecular Partners. Today, we're joined by the CEO, Patrick Amstutz; the CFO, Andreas Emmenegger; and also Seth Lewis from Investor Relations.

Just before handing over to Patrick, I will remind you that if you wish to ask a question, you can do so by entering it in the text box on the portal. Or you can email me at [email protected], and I'll ask your question for you.

In terms of disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep.

With that explained, over to you, Patrick, to set the scene with a few introductory comments.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot